| Original language | English |
|---|---|
| Article number | e0195716 |
| Pages (from-to) | 1 |
| Number of pages | 17 |
| Journal | PLOS ONE |
| Volume | 13 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 31 May 2018 |
Keywords
- PROMOTER METHYLATION
- NEUROENDOCRINE TUMORS
- METAANALYSIS
- SUPPRESSOR
- CDKN2A
- LINE1
- DNA
- TUMOR-SUPPRESSOR
Cite this
}
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer. / Walter, R. F. H.; Rozynek, P.; Casjens, S.; Werner, R.; Mairinger, F. D.; Speel, E. J. M.; Zur Hausen, A.; Meier, S.; Wohlschlaeger, J.; Theegarten, D.; Behrens, T.; Schmid, K. W.; Bruning, T.; Johnen, G.
In: PLOS ONE, Vol. 13, No. 5, e0195716, 31.05.2018, p. 1.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer
AU - Walter, R. F. H.
AU - Rozynek, P.
AU - Casjens, S.
AU - Werner, R.
AU - Mairinger, F. D.
AU - Speel, E. J. M.
AU - Zur Hausen, A.
AU - Meier, S.
AU - Wohlschlaeger, J.
AU - Theegarten, D.
AU - Behrens, T.
AU - Schmid, K. W.
AU - Bruning, T.
AU - Johnen, G.
PY - 2018/5/31
Y1 - 2018/5/31
KW - PROMOTER METHYLATION
KW - NEUROENDOCRINE TUMORS
KW - METAANALYSIS
KW - SUPPRESSOR
KW - CDKN2A
KW - LINE1
KW - DNA
KW - TUMOR-SUPPRESSOR
U2 - 10.1371/journal.pone.0195716
DO - 10.1371/journal.pone.0195716
M3 - Article
VL - 13
SP - 1
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 5
M1 - e0195716
ER -